A Randomized, Double-blind Study of the Effect of Beta-lactam [RO 490 8463] on Treatment Response in Patients Hospitalized With Bacterial Pneumonia

Trial Profile

A Randomized, Double-blind Study of the Effect of Beta-lactam [RO 490 8463] on Treatment Response in Patients Hospitalized With Bacterial Pneumonia

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Feb 2017

At a glance

  • Drugs Tomopenem (Primary) ; Ceftriaxone
  • Indications Community-acquired pneumonia
  • Focus Therapeutic Use
  • Acronyms CAPTURE
  • Sponsors Roche
  • Most Recent Events

    • 23 Feb 2010 New source identified and integrated (Roche).
    • 24 Mar 2009 Planned number of patients changed from 100 to 302 as reported by ClinicalTrials.gov.
    • 24 Mar 2009 Actual end date changed from May 2006 to Jan 2007 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top